Watch leading experts in the field of TAVR discuss the biomimetic design of the DurAVR^® THV and its impact on hemodynamics and blood flow dynamics, presented by Drs. Christopher Meduri, Susheel Kodali, João Cavalcante, Michael Reardon, Nicolas Van Mieghem, Azeem Latib, Anita Asgar and Vinayak Bapat.

Key takeaways included:

• Aortic stenosis is a disease of the valve, the arteries, and the myocardium.
• Laminar blood flow (as opposed to turbulent or chaotic blood flow) may result in positive clinical outcomes and quality of life for patients.
• 4D Flow CMR can provide significant information on flow patterns.
• First-in-Human (FIH) data from patients implanted with the biomimetic Study (EFS) patients implanted with the biomimetic DurAVR^® Transcatheter Heart Valve (THV) reveals favorable reverse remodeling.
• Preliminary 4D Flow CMR analysis of Early Feasibility Study (EFS) patients implanted with the biomimetic DurAVR^® THV reveals restoration of laminar flow.